OptimizeRx Corp
OPRXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How OptimizeRx Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-19 | Stelmakh Edward · Chief Finance & Strat Officer | Common Stock | S — Open market or private sale | −1,388 | 13.51 | SEC filing |
| 2025-10-03 | Silvestro Stephen L · Chief Executive Officer | Common Stock | S — Open market or private sale | −1,620 | 18.75 | SEC filing |
| 2025-08-28 | Spangler Patrick D · Director | Common Stock | S — Open market or private sale | −11,120 | 17.49 | SEC filing |
| 2025-03-14 | Lang James Paul · Director | Common Stock | P — Open market or private purchase | +321,408 | 7.60 | SEC filing |
| 2024-12-12 | FEBBO WILLIAM J · CEO | Common Stock | P — Open market or private purchase | +20,000 | 5.01 | SEC filing |
| 2024-01-09 | Odence-Ford Marion · General Counsel and CCO | Common Stock | S — Open market or private sale | −4,000 | 15.19 | SEC filing |
Showing 6 of 6 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-09 | Lang James Paul · Director | Common Stock | A — Grant, award, or other acquisition | +34,517 | SEC filing |
| 2026-06-09 | WASSON GREGORY D · Director | Common Stock | A — Grant, award, or other acquisition | +34,517 | SEC filing |
| 2026-06-09 | KLEMA CATHY · Director | Common Stock | A — Grant, award, or other acquisition | +34,517 | SEC filing |
| 2026-06-09 | Spangler Patrick D · Director | Common Stock | A — Grant, award, or other acquisition | +34,517 | SEC filing |
| 2026-06-09 | Vos Ellen O'Connor · Director | Common Stock | A — Grant, award, or other acquisition | +34,517 | SEC filing |
| 2026-06-09 | Presti Mariyamma Varghese · Director | Common Stock | A — Grant, award, or other acquisition | +17,258 | SEC filing |
| 2026-05-15 | Greco Theresa · Chief Commercial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −879 | SEC filing |
| 2026-05-15 | Greco Theresa · Chief Commercial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −914 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.